Wegovy And Ozempic Will Cost Less In 2027, Novo Nordisk Slashes Weight Loss Drugs Prices By Half

Wegovy And Ozempic Will Cost Less In 2027, Novo Nordisk Slashes Weight Loss Drugs Prices By Half

Credits: iStock

Text

Updated Feb 25, 2026 | 11:00 AM IST

SummaryNovo Nordisk will halve Wegovy prices and cut Ozempic 35 percent by 2027, improving access for obesity and diabetes care. GLP-1 drugs lower blood sugar, suppress appetite, aid weight loss, and WHO lists them essential for diabetes treatment.

Wegovy And Ozempic Will Cost Less In 2027, Novo Nordisk Slashes Weight Loss Drugs Prices By Half

End of Article